Načítá se...
Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor
[Image: see text] Melanoma is a lethal form of skin cancer. Despite recent breakthroughs of BRAF-V600E and PD-1 inhibitors showing remarkable clinical responses, melanoma can eventually survive these targeted therapies and become resistant. To solve the drug resistance issue, we designed and synthes...
Uloženo v:
| Vydáno v: | ACS Pharmacol Transl Sci |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American
Chemical Society
2020
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7551717/ https://ncbi.nlm.nih.gov/pubmed/33073191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00072 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|